As far as I know Shasun is the largest producer of Ibuprofen and they are entering US formulation on their own too.

Could you explain why for PI Ind? Seems AGM has not gone down well with investor community.

Added a few shares of Godrej Consumer products in the recent market correction. Currently studying about Deepak Fertilizers and Chemicals. A very nice story is brewing up there……about that I am sure…..will shortly come out with the story and details.

They already had approval for 200mg way back in 2010, this is for 400, 600 and 800. I would imagine Ibuprofen being a popular drug the market size would be big and so would be the number of players with approvals. I could find about 20 names approved for various Ibuprofen dosage on the orange book. Some one who is familiar with Ibuprofen and its technical/chemical name can dig out and provide accurate numbers.

On a related note, found this article relavent to the discussion.

And yet today, almost 25 years after the expiration of the ibuprofen patent, Advil still owns 51% of the market. That’s more than twice the combined share of all generic ibuprofen products, despite the fact that Advil is functionally equivalent to its rivals and quite a bit more expensive.

Agreed Varun, Identifying stocks is only the first step.

My finance professor used to explain PF building this way –

The three pillars of building a portfolio would be
1. Identifying the right stocks
2. Allocate appropriately among the identified names
3. Timing (not overpaying)

Like you have just said, most of us will have the same names so it is very hard to go wrong on the first step. Allocation strategies is where some portfolios perform better compared to the usual 15-20% compounders. The third step is not completely in our control is my opinion(though one should be careful not to overpay).

Thanks,
Ravi S